Article Details

Calamos Advisors LLC Takes Position in CTI BioPharma Corp. (NASDAQ:CTIC)

Retrieved on: 2023-01-02 22:46:05

Tags for this article:

Click the tags to see associated articles and topics

Calamos Advisors LLC Takes Position in CTI BioPharma Corp. (NASDAQ:CTIC). View article details on hiswai:

Excerpt

The firm acquired 233,452 shares of the biopharmaceutical company's stock, valued at approximately $1,359,000. A number of other institutional ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up